Role of angiogenic markers in the genesis of preeclampsia
Versandkostenfrei!
Versandfertig in 6-10 Tagen
53,99 €
inkl. MwSt.
PAYBACK Punkte
27 °P sammeln!
Pre-eclampsia (PE) is a worldwide public health problem, a disease of placental origin affecting the maternal endothelium. It is classically defined as de novo hypertension associated with proteinuria > 0.3 g/24 h occurring after 20 weeks of gestation and is characterized by a latent phase between the beginning of pregnancy and the onset of the disease. This opens the way to a possible screening which would allow an early management of parturients in order to reduce the complications related to this pathology.The main goal of this work is to evaluate the interest of the determination of angiog...
Pre-eclampsia (PE) is a worldwide public health problem, a disease of placental origin affecting the maternal endothelium. It is classically defined as de novo hypertension associated with proteinuria > 0.3 g/24 h occurring after 20 weeks of gestation and is characterized by a latent phase between the beginning of pregnancy and the onset of the disease. This opens the way to a possible screening which would allow an early management of parturients in order to reduce the complications related to this pathology.The main goal of this work is to evaluate the interest of the determination of angiogenic biomarkers (sFlt1 and PLGF) in the detection of preeclampsia in the first and second trimester of pregnancy. The prognostic value of PAPP-A, AFP, and free-betaHCG in the occurrence of PE was also analyzed.
Andere Kunden interessierten sich für
